CCL4-induced Chronic Liver Fibrosis Models in SD Rat

Bioanalytical Services
Phenotyping Services
Oncology PlatformMetabolism PlatformEfficacy and Pathology Platform
Anti-Tumor Drug Efficacy Evaluation
Humanized Immune Checkpoint Mouse Models and Efficacy Services
Non-GLP Toxicity Assessment Services
Metabolic Disease Efficacy Evaluation
Obesity Models and Efficacy ServicesType II Diabetes Models and Efficacy ServiceType I Diabetes Models and Efficacy ServicesAndrogenetic Alopecia (AGA) Models and Efficacy ServicesMASH Models and Efficacy ServicesChronic Liver Fibrosis Models and Efficacy ServicesAcute Liver Injury Models and Efficacy ServicesCholestasis Models and Efficacy ServicesAlcohol-related Liver Disease (ALD) Models and Efficacy ServicesGout/Hyperuricemia Models and Efficacy Services
Autoimmune Disease Efficacy Evaluation
Autoimmune Nephropathy Models and Efficacy ServicesAsthma Models and Efficacy ServicesSystemic Lupus Erythematosus (SLE) Models and Efficacy ServicesSjögren's Syndrome Models and Efficacy ServicesNeuroimmune Diseases Models and Efficacy ServicesAutoimmune Dermatoses Models and Efficacy ServicesInflammatory Bowel Disease (IBD) Models and Efficacy ServicesRheumatoid Arthritis (RA) Models and Efficacy ServicesImmune Reconstitution Autoimmune Disease Models and Efficacy Services
Neurological Disease Efficacy Evaluation
In Vitro TestingBehavioral AnalysisIn Vivo Drug Efficacy EvaluationIn Vivo Biochemical ExaminingParkinson’s Disease Rat Model
Cardiovascular Diseases Efficacy Evaluation
Heart Failure Models and Efficacy ServicesHypertension Models and Efficacy ServicesAtherosclerosis Models and Efficacy ServicesAdvanced Cardiovascular and Metabolic Complication Models and Efficacy ServicesHyperlipidemia Models and Efficacy ServicesHypertropic Cardiomyopathy Models and Efficacy ServicesStroke Models and Efficacy ServicesThrombosis Models and Efficacy Services
Cell Therapy & Gene Therapy Efficacy Evaluation
Disease Rat Models
5/6 Nephrectomy-induced Rat CKD ModelCCL4-induced Chronic Liver Fibrosis Models in SD RatSTZ-induced Type I Diabetes Model in SD RatOVX-induced Rat Osteoporosis ModelMCAO-induced CIS Model in SD Rat2K1C-induced Hypertension Model in SD Rat

Liver fibrosis is a pathological wound-healing response to chronic liver injury characterized by excessive accumulation of extracellular matrix (ECM) proteins that disrupt normal liver structure. Common causes include viral hepatitis, alcohol abuse, metabolic dysfunction, and toxic impairment. If left untreated, fibrosis may progress to cirrhosis, portal hypertension, and liver failure.

CCL4-induced chronic liver fibrosis models in SD rat

CCl4 generates toxic free radicals via CYP2E1 metabolism, causing lipid peroxidation, necrosis, and activation of hepatic stellate cells (HSCs). The CCl4-induced liver fibrosis model is a gold-standard preclinical system for studying hepatic fibrogenesis, mimicking human progression from hepatocyte injury → inflammation → fibrosis → cirrhosis.


图片1.png

Fig.1 Overview of pharmacodynamic evaluation on CCL4-induced rat chronic liver fibrosis models

 

 图片2.png

Fig.2 Body weight and serum ALT, AST, ALP, TBA and T-BIL of CCL4-induced rat chronic liver fibrosis models


Body weight curve of CCL4-induced rat chronic liver fibrosis models is shown in Fig. 2A. The serum level of ALT, AST, ALP, TBA and T-BIL were significantly higher in CCL4-induced rat chronic liver fibrosis models compared to the control group (Fig. 2B-D). Data were presented by mean ± SEM, N=25-45. *, p < 0.05; **, p < 0.01; ***, p < 0.001 and ****, p < 0.0001

 

图片3.png         

Fig.3 Histological observation of CCL4-induced rat chronic liver fibrosis models


Histopathological staining (HE and Sirius Red) showed significant vacuolar degeneration and fibrous tissue hyperplasia in CCL4-induced rat chronic liver fibrosis models.

TALK WITH OUR EXPERTS

GemPharmatech is committed to protecting and respecting your privacy, and we'll only use your personal information to administer your account and to provide the products and services you requested from us. From time to time, we would like to contact you about our products and services, as well as other content that may be of interest to you. If you consent to us contacting you for this purpose, please click below to say how you would like us to contact you:

In order to provide you with the content requested, we need to store and process your personal data. If you consent to us storing your personal data for this purpose, please click the checkbox below.

You can unsubscribe from these communications at any time. For more information on how to unsubscribe, our privacy practices, and how we are committed to protecting and respecting your privacy, please review our Privacy Policy.